Antibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN115699 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-CD105 (Endoglin / TGF-Beta1/3 Receptor) (AA 22-586) antibody
- Antibody type
- Polyclonal
- Antigen
- Recombinant Human soluble CD105/Endoglin (aa. 22 (Glu) to 586 (Leu)) derived from Insect Cells
- Description
- Protein A Chromatography
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 22-586
- Vial size
- 0.1 mg
- Storage
- Prior to and following reconstitution store the antibody undiluted at 2-8°C. DO NOT FREEZE!
- Handling
- This product is photosensitive and should be protected from light
Submitted references Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGFbeta receptor independent manner.
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.
Parker WL, Goldring MB, Philip A
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Feb;18(2):289-302
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003 Feb;18(2):289-302
Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
Fonsatti E, Del Vecchio L, Altomonte M, Sigalotti L, Nicotra MR, Coral S, Natali PG, Maio M
Journal of cellular physiology 2001 Jul;188(1):1-7
Journal of cellular physiology 2001 Jul;188(1):1-7
Endoglin, an ancillary TGFbeta receptor, is required for extraembryonic angiogenesis and plays a key role in heart development.
Arthur HM, Ure J, Smith AJ, Renforth G, Wilson DI, Torsney E, Charlton R, Parums DV, Jowett T, Marchuk DA, Burn J, Diamond AG
Developmental biology 2000 Jan 1;217(1):42-53
Developmental biology 2000 Jan 1;217(1):42-53
Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
Barbara NP, Wrana JL, Letarte M
The Journal of biological chemistry 1999 Jan 8;274(2):584-94
The Journal of biological chemistry 1999 Jan 8;274(2):584-94
Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1.
McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J
Nature genetics 1994 Dec;8(4):345-51
Nature genetics 1994 Dec;8(4):345-51
Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.
Cheifetz S, Bellón T, Calés C, Vera S, Bernabeu C, Massagué J, Letarte M
The Journal of biological chemistry 1992 Sep 25;267(27):19027-30
The Journal of biological chemistry 1992 Sep 25;267(27):19027-30
No comments: Submit comment
No validations: Submit validation data